CP
MRVI icon

CenterBook Partners’s Maravai LifeSciences MRVI Stock Holding History

CenterBook Partners’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$349K Buy
+55,910
New +$241K 0.02% 603
2025
Q4 		– Sell
-1,691,873
Closed -$4.86M – 641
2025
Q3 		$4.86M Buy
1,691,873
+57,365
+4% +$146K 0.24% 112
2025
Q2 		$3.94M Buy
1,634,508
+276,908
+20% +$582K 0.22% 124
2025
Q1 		$3M Buy
1,357,600
+545,674
+67% +$2.16M 0.19% 138
2024
Q4 		$4.42M Buy
+811,926
New +$5.22M 0.26% 114

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

CenterBook Partners's MRVI Position: Q2 2026 in Review

CenterBook Partners opened a new position in Maravai LifeSciences (MRVI) in Q2 2026: 55,910 shares worth $349K. The stake represents 0.02% of the portfolio and ranks #603 among its holdings. This is a return to the name: CenterBook Partners previously reported a position in MRVI as recently as Q3 2025.

CenterBook Partners first reported a position in MRVI in Q4 2024 and has held it in 5 quarters since. The position peaked at $4.86M in Q3 2025. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • CenterBook Partners held 55,910 shares of Maravai LifeSciences worth $349K as of Q2 2026.
  • Maravai LifeSciences was a new CenterBook Partners position in Q2 2026.
  • Maravai LifeSciences made up 0.02% of CenterBook Partners's portfolio in Q2 2026, its #603 holding.
  • CenterBook Partners first reported a position in Maravai LifeSciences in Q4 2024 and has held it in 5 quarters since.
  • CenterBook Partners's Maravai LifeSciences position peaked at $4.86M in Q3 2025.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.